Ireland· IE-PA-EU/1/25/1996/001
Waskyra 2-10 × 106 cells/mL dispersion for infusion
A other hematological agents product containing autologous cd34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human wiskott-aldrich syndrome protein, registered in Ireland by Fondazione Telethon Ets. The same ATC class is registered in 4 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Autologous cd34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human wiskott-aldrich syndrome protein is registered in 4 of 19 countries.
Countries holding a registration under ATC B06 (other hematological agents), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 1 of them publish a price we can compare per daily dose
Autologous cd34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human wiskott-aldrich syndrome protein · ATC B06
4 / 19 countries
- Denmark
- Finlandprice
- Ireland
- Netherlands
The record
At a glance
HPRA (Ireland)- Active substance
- Autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human Wiskott-Aldrich syndrome protein
- Manufacturer
- Fondazione Telethon Ets
- Country
- Ireland (IE)
- ATC code
- B06
- ATC class
- OTHER HEMATOLOGICAL AGENTS
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/25/1996/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under B06
Other hematological agents, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/af678a65-869d-4b9d-b278-89ab3a3b8ac6 GET /v1/drugs/af678a65-869d-4b9d-b278-89ab3a3b8ac6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersion for infusion",
"routes": [
"Intravenous use"
],
"source": "hpra",
"atc_all": [
"B06"
],
"strength": null,
"pa_number": "EU/1/25/1996/001",
"substances": [
"Autologous CD34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human Wiskott-Aldrich syndrome protein"
],
"legal_basis": "Known active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "09/01/2026",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about autologous cd34+ haematopoietic stem cells transduced ex vivo with a lentiviral vector encoding human wiskott-aldrich syndrome protein.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.